The pharma has also partnered with several Chinese biotechs to develop innovative medicines. In November 2023, AstraZeneca ...

AstraZeneca’s presence in South Africa has become a driving force in global health research, contributing significantly to respiratory, cardiovascular, and oncology therapeutic areas. The ...

AstraZeneca's China president has been detained by Chinese authorities amid investigation into illegal importation and ...

Jing'an also launched the "Quality Products Import Demonstration Zone", a strategic initiative aimed at strengthening its ...

With an array of new medicines and medical devices on display, global medical companies are looking to tap further into the ...

"China market is one of the most attractive markets for Edwards," said Leo Tam, senior director of the business unit of Transcatheter Aortic Valve Replacement, Edwards Lifesciences China, citing a lot ...

What's more, 11 Fortune Global 500 pharmaceutical corporations – Johnson & Johnson, Roche, MSD, Pfizer, Novartis, Bayer, Sanofi, AstraZeneca, GSK, Eli Lilly and Novo Nordisk – will show their ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that the Company will hold a conference call on Wednesday, November 13, 2024, at 2 p.m. CET / 8 a.m. ET ...

AstraZeneca stock tumbles as Chinese probe widens, implicating executives in insurance fraud and drug import violations ...

AstraZeneca (AZN) stock falls as a Chinese probe into drug importations and data privacy implicates senior and former ...

BMO Capital Markets analyst Etzer Darout in a note to investors said the insurance fraud probe represents a “headline risk” ...